Radiopharmaceutical Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The Radiopharmaceutical Market was worth USD 4.31 Billion in 2020 and is further projected to reach USD 6.43 Billion by 2028, at a CAGR of 6% during the forecast period 2022-2028.

Radiopharmaceuticals are unique preparations containing radioactive isotopes used in the clinical realm for diagnosis and treatment. These medicines are administered by radiology pharmacists, medical professionals specializing in nuclear medicine. They are taken in pill form or injected into a vein or hole in the patient’s body. When it reaches the target location, it releases a radioactive material to destroy the tumor cells. As a result, radiopharmaceuticals are used to treat thyroid, brain, lymphoma, and other types of cancer that have spread to the bone.

Market Segments

On the basis of product

• Actinium-225
• Lutetium-177
• Radium-223
• Holmium-166
• Other

On the basis of the applications

• Oncology
• Cardiology
• Other

On the basis of Product Type:

• Diagnostic Nuclear Medicine
• Therapeutic Nuclear Medicine

Key Players

• Bracco Imaging
• Bayer
• Mallinckrodt
• Nordion
• Triad Isotopes
• Lantheus
• GE Healthcare
• China Isotope & Radiation
• Jubilant Pharma
• Eli Lilly

Scope of the Report

The research study analyzes the global Radiopharmaceutical industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Radiopharmaceutical Market Report

1. What was the Radiopharmaceutical Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of Radiopharmaceutical Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Radiopharmaceutical Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.